false
0001002910
0001002910
2026-03-04
2026-03-04
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of report (Date of earliest event reported): March 4, 2026
AMEREN CORPORATION
(Exact name of registrant as specified in its charter)
| Missouri |
1-14756 |
43-1723446 |
(State or other jurisdiction of
incorporation) |
(Commission
File Number) |
(I.R.S. Employer
Identification
No.) |
1901 Chouteau Avenue, St. Louis, Missouri 63103
(Address of principal executive offices and
Zip Code)
Registrant’s telephone number, including
area code: (314) 621-3222
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
¨ Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨ Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title
of each class |
|
Trading
Symbol(s) |
|
Name
of each exchange on
which registered |
|
Common
Stock, $0.01 par value per share |
|
AEE |
|
New
York Stock Exchange |
Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange
Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ¨
If an emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant
to Section 13(a) of the Exchange Act. ¨
On March 4, 2026, Ameren Corporation (“Ameren”)
sold $400 million principal amount of its 5.00% Senior Notes due 2036 (the “Notes”). The Notes were offered pursuant
to a Registration Statement on Form S-3 (File No. 333-274977), which became effective on October 13, 2023, and a Prospectus Supplement
dated February 26, 2026, to a Prospectus dated October 13, 2023. Ameren received net offering proceeds of approximately $396.6 million,
before expenses, upon closing of the transaction.
This Current Report on Form 8-K is being filed
to report as exhibits certain documents in connection with the offering of the Notes.
| ITEM 9.01 | Financial Statements and Exhibits. |
| 1 | Underwriting Agreement, dated February 26, 2026, between Ameren and BNY Mellon Capital Markets,
LLC, J.P. Morgan Securities LLC, RBC Capital Markets, LLC, U.S. Bancorp Investments, Inc. and Wells Fargo Securities, LLC, as the
several underwriters named therein. |
| 4.1* | Indenture, dated as of December 1, 2001, by and between Ameren and The Bank of New York Mellon Trust
Company, N.A., as successor trustee, (“Ameren Indenture”) (Exhibit 4.5, File No. 333-81774). |
| 4.2* | First Supplemental Indenture, dated as of May 19, 2008, to the Ameren Indenture (June 30, 2008 Form
10-Q, Exhibit 4.1, File No. 1-14756). |
| 4.3 | Company Order, dated March 4, 2026, establishing the Notes. |
| 5.1 | Opinion of Stephen C. Lee, Esq., Vice President and Deputy General Counsel of Ameren, regarding
the legality of the Notes (including consent). |
| 5.2 | Opinion of Morgan, Lewis & Bockius LLP regarding the legality of the Notes (including consent). |
| 104 | Cover Page Interactive Data File (formatted as Inline XBRL). |
| * | Incorporated by reference as indicated. |
SIGNATURES
Pursuant to the requirements of the Securities
Exchange Act of 1934, Ameren has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| | AMEREN CORPORATION |
| (Registrant) | |
| | | |
| By: | /s/
Leonard P. Singh |
| Name: | Leonard P. Singh |
| Title: | Executive Vice President and Chief
Financial Officer |
Date:
March 4, 2026